CSI Market
Sign In | Register

Akari Therapeutics Plc (AKTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access AKTX quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Akari Therapeutics Plc manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent5.20
Cash & Short-term Investments5.00
Accounts Receivable, Related Parties, Current0.00
Deferred Offering Costs DE0.00
Other Current Assets0.07
Prepaid Expense, Current AS0.19
Total Current Assets5.46
Equipment/Property/Plant Net0.00
Goodwill net8.43
Intangible Assets34.00
Long-term investments5.26
Tax Assets, Noncurrent0.69
Other Assets, Noncurrent0.00
Total Assets47.89
Liabilities
Accounts Payable, Current AC8.77
Accrued Liabilities, Current AC0.78
Financial Instruments0.23
Notes Payable, Current NO0.08
Other Liabilities, Current1.16
Total Current Liabilities12.35
Convertible Debt LO0.67
Total Long-term Debt0.67
Derivative Liability, Noncurrent DE0.23
Accrued Income Taxes, Noncurrent7.06
Other liabilities, Noncurrent6.31
LiabilityRelatedToDepositsReceivedForShareSubscriptions-
Warrant Liabilities Current0.06
Total Liabilities19.56
Stockholders' Equity
Capital Redemption Reserve59.34
Common Stock Value0.00
Additional Paid In Capital Common Stock234.32
Retained Earnings / Accumulated Deficit-264.55
Accumulated Other Comprehensive Income-0.78
Other Equity-0.78
Common Stockholder's Equity28.33
Total Stockholder's Equity28.33
Liabilities & Stockholder's Equity47.89
4 historic quarters locked

Sign in to unlock the full Akari Therapeutics Plc balance sheet history.

Sign In Create Free Account

About Akari Therapeutics Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 30, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013664

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License